Board of Directors of CytoDyn Inc. announced a leadership transition plan. Effective immediately, Antonio Migliarese, currently CytoDyn's Chief Financial Officer, has been appointed interim President. The Board of Directors terminated the employment of Nader Z. Pourhassan, Ph.D., as President of the Company and he is no longer a member of the Board of Directors, effective January 24, 2022.

The rest of CytoDyn's executive team is continuing with the Company and is united in their commitment to advance the Company's objectives.